Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Baxter International
(NY:
BAX
)
33.78
-0.44 (-1.27%)
Streaming Delayed Price
Updated: 2:23 PM EST, Nov 12, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Baxter International
< Previous
1
2
3
4
5
6
7
Next >
Baxter Expects Hurricane Helene Aftermath To Impact Near-Term Financial Outlook
November 08, 2024
Baxter International's Q3 2024 adjusted EPS of $0.80 beat estimates, driven by strong Medical Products & Therapies sales and improved supply chain management.
Via
Benzinga
Topics
Economy
Exposures
Supply Chain
Uncovering Potential: Baxter Intl's Earnings Preview
November 07, 2024
Via
Benzinga
3 Shareholder Yield Stocks For Growth And Dividends
October 18, 2024
Top shareholder yield stocks are generating returns by paying dividends, buying back stock, and reducing debt.
Via
Talk Markets
US Hospitals Face Critical IV Fluid Shortage After Baxter Facility Shuts Down Due To Hurricane Helene
October 18, 2024
The U.S. faces a critical shortage of IV fluids due to Hurricane Helene's damage to Baxter's North Carolina plant, forcing hospitals to delay surgeries. Federal efforts to rebuild and import supplies...
Via
Benzinga
Baxter's North Carolina Plant Recovery Underway After Hurricane Flooding, Starts Product Imports
October 15, 2024
Baxter International resumes IV fluid shipments from international sites after Hurricane Helene disrupted production at its North Carolina plant, which supplies 60% of U.S. IV fluids. FDA approves...
Via
Benzinga
Exposures
Product Safety
Beyond The Numbers: 6 Analysts Discuss Baxter Intl Stock
October 01, 2024
Via
Benzinga
“Jackets And Packets” Stock Market (And Sentiment Results)
September 13, 2024
Revenues continue to grow, Free Cash Flow recovering, Margins high, Stock Price subdued.
Via
Talk Markets
The Latest Analyst Ratings For Baxter Intl
August 07, 2024
Via
Benzinga
Assessing Baxter Intl: Insights From 4 Financial Analysts
July 02, 2024
Via
Benzinga
Baxter's North Carolina Facility Manufactures ~60% Of IV Fluids And Peritoneal Dialysis Solutions, Senator Demands Immediate Action To Protect Patient Care Amid Shortage
October 09, 2024
U.S. Senator Amy Klobuchar has called on HHS Secretary Xavier Becerra to address the national IV solution shortage following the closure of Baxter's facility due to Hurricane Helene, which compromises...
Via
Benzinga
Hurricane Helene Economic Price Tag Could Be $34 Billion; The Stock Market Impact
October 01, 2024
Moody's Analytics projects major costs.
Via
Investor's Business Daily
Hurricane Helene Shutters Baxter International's Key Manufacturing Hub In North Carolina
September 30, 2024
Baxter International shuts down its largest manufacturing facility in North Carolina due to Hurricane Helene's damage. Shares fall.
Via
Benzinga
Medtronic Inc. Dividend Stock Analysis - Sunday, Sept. 29
September 29, 2024
Medtronic Inc. is a global medical device manufacturer with leadership positions in the pacemaker, defibrillator, orthopedic, diabetes management, and other medical markets. Here are some highlights...
Via
Talk Markets
Medtronic Recalls Some Video Laryngoscopes Due To Increased Risk For Battery Overheat, Explosion
September 05, 2024
Medtronic recalls devices over battery risks that could lead to explosions and updates usage instructions.
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
How Is The Market Feeling About Baxter Intl?
June 07, 2024
Via
Benzinga
Unveiling 5 Analyst Insights On Baxter Intl
May 30, 2024
Via
Benzinga
Rivian, Chipotle Mexican And Sirius XM Are Among Top 10 Large Cap Losers Last Week (Aug 11-Aug 17): Are The Others In Your Portfolio?
August 18, 2024
Ten large-cap stocks were the worst performers last week, with TME, MBLY, RIVN, CMG, LINE, SIRI, HSY, BAX, BR, and UTHR all seeing declines.
Via
Benzinga
Baxter Tumbles On $3.8 Billion Kidney Deal — Why Investors Expected More
August 13, 2024
The company is selling its Vantive Kidney Care business to Carlyle, a private equity investor in the medtech space.
Via
Investor's Business Daily
Baxter Seals $3.8B Deal With Carlyle For Its Kidney Care Segment
August 13, 2024
Baxter has agreed to sell its Kidney Care segment to Carlyle for $3.8 billion. Baxter will receive about $3.5 billion in cash, with net after-tax proceeds estimated at $3 billion. Post-sale, Baxter...
Via
Benzinga
BAX Stock Earnings: Baxter Intl Beats EPS, Beats Revenue for Q2 2024
August 06, 2024
BAX stock results show that Baxter Intl beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Baxter Lifts Annual Outlook After Strong Q2 Beat, Medical Devices Sales
August 06, 2024
Baxter surpasses Q2 expectations with adjusted EPS of $0.68 and sales of $3.812 billion. Sales rose 3% reported and 4% constant currency, driven by Pharmaceuticals, Medical Products, and Healthcare...
Via
Benzinga
3 Contrarian Stock Picks to Buy Against the Market Consensus
August 05, 2024
Discover three contrarian stock picks with strong fundamentals that defy current market trends and offer significant rebound potential.
Via
InvestorPlace
Carlyle's $4B Purchase Of Baxter's Kidney Division Backed By Ares And HPS Financing
July 24, 2024
Ares Management and HPS Investment Partners lead a $3 billion credit facility to support Carlyle's potential acquisition of Baxter's kidney-care division, highlighting the evolving role of private...
Via
Benzinga
AutoNation, Baxter International And Other Big Stocks Moving Lower In Monday's Pre-Market Session
July 15, 2024
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
July 10, 2024
Via
Benzinga
3 Bargain Bin Stocks with Millionaire-Maker Potential
July 09, 2024
Three bargain stocks with substantial upside from potential price-to-earnings multiple reratings and accretive buybacks.
Via
InvestorPlace
Carlyle Eyes $4B Acquisition Of Baxter's Kidney-Care Unit Vantive: Report
July 08, 2024
Carlyle is negotiating to acquire Baxter International's kidney-care spinoff, Vantive, in a $4 billion deal, including debt. The deal reflects a significant move in private-equity dealmaking and...
Via
Benzinga
“Cash Flow Is The Name Of The Game” Stock Market
July 04, 2024
Liquidity is becoming a problem and the Fed (and other Central Bankers) know it. Higher for longer is a luxury they can no longer afford.
Via
Talk Markets
Topics
Economy
Exposures
Interest Rates
7 Deeply Undervalued Stocks to Buy Now or Regret Later
June 05, 2024
Unlock massive upside by buying these deeply undervalued stocks at fire-sale prices. These companies have staying power and could bounce back.
Via
InvestorPlace
3 Dividend Growth Stocks For Long-Term Returns
May 24, 2024
One way to measure the quality of a dividend stock is by its dividend history. Stocks with established histories of dividend growth may be likely to continue growing their dividends moving forward....
Via
Talk Markets
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.